Pegfilgrastim effectively mobilizes PBSC in a poor mobilizer multiple myeloma patient

European Journal of Haematology

Volumn 76, Issue 5, 2006, Pages 436-439

  Malerba, Lara ^a   Mele, Anna ^a   Leopardi, Giuliana ^a   Stramigioli, Stefania ^b   Politi, Patrizia ^c   Visani, Giuseppe ^a,d  

^a Department of Haematology ^*  (Italy)

^b Clinical Pathology   (Italy)

^c Transfusional Center Hospital   (Italy)

^d SAN SALVATORE HOSPITAL   (Italy)

Author keywords

Multiple myeloma; Pegfilgrastim; Stem cell mobilization

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; IMMUNOGLOBULIN G; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE; ZOLEDRONIC ACID;

AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE PAIN; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CASE REPORT; DISEASE COURSE; DRUG EFFECT; DRUG MEGADOSE; DRUG RESPONSE; ERYTHROCYTE TRANSFUSION; EXPERIENCE; HUMAN; LYMPHOCYTE COUNT; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; SIDE EFFECT; SKELETAL PAIN; STEM CELL MOBILIZATION; THROMBOCYTE TRANSFUSION; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MULTIPLE MYELOMA; NEOPLASM STAGING; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 33645719088     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00627.x     Document Type: Article

References (26)

1. H aas R H ohaus S G oldschmidt H W itt B H unstein W. Hematopoietic growth factors for the mobilization of peripheral blood stem cells. J Hematother 1993 2 357 359.
2. K obbe G S ohngen D B auser U et al. Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma. Ann Hematol 1999 78 456 462.
3. 2) and granulocyte colony-stimulating factor in patients with multiple myeloma. Bone Marrow Transplant 1996 17 691 697.
4. K oenigsmann M J entsch -U llrich K M ohren M B ecker E H eim M F ranke A. The role of diagnosis in patients failing peripheral blood progenitor cell mobilization. Trasfusion 2004 44q9 777 784.
5. H aas R M ohle R F ruhauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994 83 3787 3794.
6. L ie AK H ui CH R awling T et al. Granulocyte colony-stimulating factors (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSF. Bone Marrow Transplant 1998 22 853 857.
7. G azitt Y F reytes CO C allander N et al. Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization. J Hematother 1999 8 173 183.
8. S tockerl -G oldstein KE R eddy SA H orning SF et al. Favorable treatment outcome in non-Hodgkin's lymphoma patients with 'poor' mobilization of peripheral blood progenitor cells. Biol Blood Marrow Transplant 2000 6 506 512.
9. S ugrue MW W illiams K P ollock BH et al. Characterization and outcome of 'hard to mobilize' lymphoma patients undergoing autologous stem cell transplantation. Leuk Lymphoma 2000 39 509 519.
10. K essinger A S harp JG. The whys and hows of hematopoietic progenitor and stem cell mobilization. Bone Marrow Transplant 2003 31 319 329.
11. T arella C B occadoro M O mede P et al. Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma. Bone Marrow Transplant 1993 11 271 277.
12. C arral A de la R ubia J M artin G et al. Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies. Leuk Res 2003 27 5 12.
13. K eating S S uciu S de W itte T et al. The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-Gimema AML-10 trial. Leukemia 2003 17 60 67.
14. V isani G L emoli RM T osi P et al. Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients. Br J Haematol 1999 105 775 779.
15. M ele A L eopardi G S paraventi G et al. Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia. Eur J Haematol 2005 74 277 281.
16. Z amboni WC. Pharmacokinetics of pegfilgrastim. Pharmacotherapy 2003 23 9S 14S.
17. M olineux G K instler O B riddell B et al. A new form of filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans. Exp Hematol 1999 27 1724 1734.
18. D e H aan G A usema A W ilkens M M olineux G D ontje B. Efficient mobilization of haematopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony-stimulating factor in mouse strains with distinct marrow-cell pool sizes. Br J Haematol 2000 110 638 646.
19. S teidl U F enk R B runs I et al. Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplant 2004 5q10 1 4.
20. + stem cells in patients undergoing autologous stem cell transplant. Blood 2004 104 2115 (abstr).
21. F reuhauf S T imon S B uss EC T opaly J H o AD G oldschmidt H. Sufficient mobilization of peripheral blood stem cells by single dose application of pegylated G-CSF in patients with multiple myeloma, interim analysis of a phase II study. Blood 2004 104 946(abstr).
22. + peripheral blood progenitor cells in patients with lymphoid malignancies and solid tumours. Bone Marrow Transplant 2004 33 (Suppl 1): 147.
23. + peripheral blood stem cells in patients with lymphoid malignancies and solid tumors. Blood 2004 104 2922 (abstr).
24. + cells in chemotherapy naïve subjects with solid tumors: initial results of a phase 1-2 study. Blood 2004 104 2687.5 (abstr).
25. I sidori A T ani M B onifazi F et al. Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. Haematologica 2005 90 225 231.
26. B runs I S teidl U S cheid C et al. Transplantation of peripheral blood stem cells mobilized by chemotherapy and single dose pegylated G-CSF in patients with multiple myeloma: equivalence of 6 mg and 12 mg pegfilgrastim. Blood 2004 104 2868 (abstr).